足三里穴位注射甲氧氯普胺配合中药旋覆代赭汤加减治疗卒中后顽固性呃逆的临床观察  被引量:6

Clinical observation of injection of methoxyclopramide at Zusanli acupoint combined with Chinese medicine Xuanfu Daizhe decoction in the treatment of intractable hiccup after stroke

在线阅读下载全文

作  者:刘若斌 胡卫武 龙安国 Liu Ruobin;Hu Weiwu;Long Anguo

机构地区:[1]湖南中医药大学,湖南长沙410208 [2]湖南中医药大学附属常德医院,湖南常德415000

出  处:《中医临床研究》2021年第18期33-35,共3页Clinical Journal Of Chinese Medicine

摘  要:目的:探讨足三里穴位注射甲氧氯普胺配合中药旋覆代赭汤加减治疗卒中后顽固性呃逆的疗效,为卒中后顽固性呃逆提供有效的干预措施。方法:选取常德市第一中医医院2020年4月-2020年10月收治入院的65例脑卒中后出现顽固性呃逆症状的患者作为研究对象,将其随机分为对照组、观察组。对照组31例予以临床上较为常规的肌内注射盐酸氯丙嗪注射液,观察组34例予以足三里穴位注射甲氧氯普胺注射液配合中药旋覆代赭汤加减,治疗周期为5 d。结果:观察组治疗总有效率(91.18%,30/34)明显优于对照组(83.87%,26/31)(P<0.05)。结论:足三里穴位注射甲氧氯普胺配合中药旋覆代赭汤加减治疗卒中后顽固性呃逆具有可靠疗效,值得临床推广。Objective:To explore the effect of Zusanli acupoint(足三里穴位,ST36)injection of metoclopramide combined with modified Xuanfu Daizhe decoction(旋覆代赭汤)on intractable hiccup after stroke,so as to provide effective intervention measures for intractable hiccup after stroke.Methods:65 patients with intractable hiccup after stroke admitted to Changde First Hospital of Traditional Chinese Medicine from April 2020 to October 2020 were randomly divided into the control group and the observation group.31 cases in the control group were given chlorpromazine hydrochloride injection,34 cases in the observation group were given Zusanli acupoint(ST36)injection of metoclopramide injection combined with modified Xuanfu Daizhe decoction.The treatment period was 5 days.Results:The total effective rate of the observation group(91.18%,30/34)was significantly better than that of the control group(83.87%,26/31)(P<0.05).Conclusion:Zusanli acupoint(ST36)injection of metoclopramide combined with modified Xuanfu Daizhe decoction has a reliable effect on intractable hiccup after stroke,which is worthy of clinical promotion.

关 键 词:顽固性呃逆 卒中 穴位注射 甲氧氯普胺 

分 类 号:R256.31[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象